Long-term mortality after screening for colorectal cancer.
Aasma Shaukat, Steven J Mongin, Mindy S Geisser...
https://pubmed.ncbi.nlm.nih.gov/24047060/Actively Recruiting
Led by Corporacion Parc Tauli · Updated on 2026-06-22
10084
Participants Needed
1
Research Sites
13 weeks
Total Duration
Colorectal cancer is a major cause of death in Catalonia, and early detection programs using the fecal immunochemical test FIT have proven effective in reducing both incidence and mortality. However, the success of these programs depends on high participation rates, which currently stand at 42% in the Valls Occidental region, below the recommended 65% minimum. This randomized controlled trial aims to evaluate whether sending a reminder SMS can increase participation in the colorectal cancer screening program among individuals aged 50 to 69 years. Participants are divided into two groups. The control group receives the standard care, which includes an initial invitation letter at week 0 and a postal reminder letter at week 6 if they do not participate. The intervention group also receives the initial invitation letter at week 0, followed by a one-way SMS reminder sent exactly five weeks after the invitation if they have not completed the FIT. Non-participants in both groups receive the postal reminder letter at week 6. The SMS is sent through a secure messaging platform and was optimized for clarity and cultural acceptance. During the study, participation rates will be tracked up to three months after the initial invitation. Researchers will also measure the time to participation and the number of reminder letters sent. Statistical analyses will compare participation rates and response times between groups. The study is conducted within the framework of the regional colorectal cancer screening program and coordinated by the Cancer Screening Unit of the Consorci Corporaci Sanitria Parc Taul. The total follow-up period for participation is three months after the initial invitation.
CONDITIONS
Impact of SMS Messaging on Participation in Colorectal Cancer Screening
A
Anna Selva Olid, PhD
M
Marina Lleal Custey, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Corporacion Parc Tauli
Lead Sponsor
Universitat Autonoma de Barcelona
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 3 months
Participants receive an initial invitation letter at week 0. Those who have not participated by week 5 may receive a reminder SMS (intervention group) or proceed with standard postal reminder letters (control group) at week 6.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aasma Shaukat, Steven J Mongin, Mindy S Geisser...
https://pubmed.ncbi.nlm.nih.gov/24047060/Désirée Schliemann, Min Min Tan, Wilfred Mok Kok Hoe...
https://pubmed.ncbi.nlm.nih.gov/35969450/P Hewitson, P Glasziou, L Irwig...
https://pubmed.ncbi.nlm.nih.gov/17253456/Laura Camilloni, Eliana Ferroni, Beatriz Jimenez Cendales...
https://pubmed.ncbi.nlm.nih.gov/23663511/Nuria Vives, Carmen Vidal, Ena Niño de Guzman...
https://pubmed.ncbi.nlm.nih.gov/39208325/Catherine Uy, Jennifer Lopez, Chau Trinh-Shevrin...
https://pubmed.ncbi.nlm.nih.gov/28838885/Nuria Vives, Albert Farre, Gemma Ibáñez-Sanz...
https://pubmed.ncbi.nlm.nih.gov/33481914/J S Mandel, T R Church, J H Bond...
https://pubmed.ncbi.nlm.nih.gov/11096167/Nuria Vives, Noemie Travier, Albert Farre...
https://pubmed.ncbi.nlm.nih.gov/39083331/Corporacion Parc Tauli
Lead Sponsor
Universitat Autonoma de Barcelona
Collaborating Sponsor